Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer

Tissue Antigens

Volumn 78, Issue 2, 2011, Pages 120-128

  Cao, M ^a   Yie, S M ^a,b,c   Liu, J ^c   Ye, S R ^c   Xia, D ^c   Gao, E ^c  

^a Sichuan Academy of Chinese Medical Science   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Chengdu Bioengineering Institute for Cancer Research   (China)

Author keywords

Cancer diagnosis; Colorectal cancer; Esophageal squamous cell cancer; Gastric cancer; Non small cell lung cancer; Plasma; Soluble hla g

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HLA G ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HLA-G ANTIGENS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959928969     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01716.x     Document Type: Article

References (35)

1. Kirszenbaum M, Djoulah S, Hors J, Prost S, Dausset J, Carosella ED. Polymorphism of HLA-G gene and protein. J Reprod Immunol 1999: 43: 105-9.
2. Mallet V, Blaschitz A, Crisa L et al. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83 (+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 1999: 11: 889-98.
3. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003: 64: 1039-44.
4. Cirulli V, Zalatan J, McMaster M et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006: 55: 1214-22.
5. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 2004: 104: 3153-60.
6. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992: 89: 3947-51.
7. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5: -G6; and -G7 transcripts in human transfected cells. Hum Immunol 2000: 61: 1138-49.
8. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008: 29: 125-32.
9. Ye SR, Yang H, Li K, Dong DD, Lin X, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007: 20: 375-83.
10. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin X. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 2007: 128: 1002-09.
11. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin X. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007: 58: 267-74.
12. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin X. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007: 14: 2721-29.
13. He X, Dong DD, Yie SM et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 2010: 17: 1459-69.
14. Nückel H, Rebmann V, Dürig J, Dührsen U, Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005: 105: 1694-98.
15. Cai MY, Xu YF, Qiu SJ et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009: 15: 4686-93.
16. Singer G, Rebmann V, Chen YC et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003: 9: 4460-64.
17. Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001: 92: 369-76.
18. Leleu X, Le Friec G, Facon T et al. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res 2005: 11: 7297-303.
19. Gros F, Sebti Y, de Guibert S et al. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006: 8: 223-30.
20. Sebti Y, Le Maux A, Gros F et al. Expression of functional soluble human leukocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol 2007: 138: 202-12.
21. Zhu CB, Wang CX, Zhang X, Zhang J, Li W. Serum HLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer 2011: 128: 617-22.
22. Morandi F, Levreri I, Bocca P et al. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res 2007: 67: 6433-41.
23. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E in collaboration with Sobin LH and pathologists from 14 countries. World Health Organization International Histological Classification of Tumours. Histological Typing of Lung and Pleural Tumours, 3rd edn Berlin: Springer-Verlag, 1999.
24. Fenogilo-Preiser C, Carneiro F, Correa P. Gastric carcinoma. In: Hamilton S, Aaltonin L, eds. Pathology and Genetics. Tumors of the Digestive System, Vol. 1. Lyon: Lyon Press, 2000, p 37 - 52
25. Herman P, Sobbing LH. UICC/TNM Classification of Malignant Tumors, 4th edn New York: Springer-Vela, 1987, p 47-9.
26. Sobin H, Wittekind C, eds. UICC: TNM Classification of Malignant Tumors, 6th edn New York: John Wiley, 2002, p 60-4.
27. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004: 191: 525-29.
28. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000: 101: 191-200.
29. Orosz F, Ovádi J. A simple method for the determination of dissociation constants by displacement ELISA. J Immunol Met 2002: 270: 155-62.
30. Harlow E, Lane D. Using Antibodies: A Laboratory Manual, 2nd edn Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999.
31. Hundt S, Haug U, Brenner H. Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 2007: 16: 1935-53.
32. Sung HJ, Cho JY. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 2008: 41: 615-25.
33. Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer 2009: 101: 1-6.
34. di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis 2008: 40: 523-30.
35. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008: 58: 71-96.